Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Leonard Seibold to Angiogenesis Inhibitors

This is a "connection" page, showing publications Leonard Seibold has written about Angiogenesis Inhibitors.

 
Connection Strength
 
 
 
0.630
 
  1. Miller DC, Christopher KL, Patnaik JL, Lynch AM, Seibold LK, Mandava N, Taravella MJ. Posterior Capsule Rupture during Cataract Surgery in Eyes Receiving Intravitreal anti-VEGF Injections. Curr Eye Res. 2021 02; 46(2):179-184.
    View in: PubMed
    Score: 0.165
  2. Torres JA, Fischer NA, Seibold LK, Pantcheva MB, Kahook MY, SooHoo JR. A Survey of Patient Perceptions and Preferences for Glaucoma Treatment with Intravitreal Injections. Ophthalmol Glaucoma. 2018 Jul - Aug; 1(1):61-65.
    View in: PubMed
    Score: 0.143
  3. SooHoo JR, Seibold LK, Pantcheva MB, Kahook MY. Aflibercept for the treatment of neovascular glaucoma. Clin Exp Ophthalmol. 2015 Dec; 43(9):803-7.
    View in: PubMed
    Score: 0.116
  4. SooHoo JR, Seibold LK, Kahook MY. The link between intravitreal antivascular endothelial growth factor injections and glaucoma. Curr Opin Ophthalmol. 2014 Mar; 25(2):127-33.
    View in: PubMed
    Score: 0.106
  5. SooHoo JR, Seibold LK, Kahook MY. Recent advances in the management of neovascular glaucoma. Semin Ophthalmol. 2013 May; 28(3):165-72.
    View in: PubMed
    Score: 0.100
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)